Association of Systemic Inflammatory and Immune Indices With Survival in Canine Patients With Oral Melanoma, Treated With Experimental Immunotherapy Alone or Experimental Immunotherapy Plus Metronomic Chemotherapy

Abstract

Analysis of the expression of inflammatory markers before starting treatment in human patients with cancer helps to predict outcomes and prognosis; however, there have been few studies on this topic in veterinary medicine. The present study aimed to evaluate inflammatory indices before treatment with autologous antitumor vaccine alone or this vaccine plus metronomic chemotherapy (MC) to predict response and prognosis. The indices included the neutrophil–lymphocyte ratio (NRL), platelet–lymphocyte ratio (PLR), monocyte–lymphocyte ratio (MLR), systemic immune-inflammation index (SII), C-reactive-protein–albumin ratio (CRP/ALB), lactate dehydrogenase level (LDH), frequency of blood lymphocyte subsets (CD4+, CD8+, Treg, and CD4/CD8 ratio) and frequency of blood myeloid-derived suppressor cells (MDSCs: monocytic [M]- MDSCs, and granulocytic [PMN]-MDSCs). Blood samples were collected from 25 dogs with oral melanoma treated with the autologous antitumor vaccine and from nine dogs that received MC plus vaccine before surgery. There were no statistically significant differences in the progression-free survival (PFS) or overall survival (OS) between the groups. In addition to the clinical stage, the CRP/ALB ratio and blood circulating Tregs in the univariate analysis showed an association with PFS and OS, and thus were selected for multivariable analysis. The CRP/ALB ratio was associated with PFS [hazard ratio (HR), 1.1; 95% confidence interval (CI), 1.0–1.1; p = 0.017] and OS [HR, 1; 95%CI, 1.0–1.1; p = 0.023]. Similarly, Treg was associated with PFS (HR, 1.6; 95% CI, 1.2–2.1; p = 0.001) and OS (HR, 1.6; 95% CI, 1.2–2.1; p = 0.001). Furthermore, canine patients with a CRP/ALB ratio above the cut-off point of 1.9 (established by receiver operating characteristic curve analysis) had worse PFS and OS, indicating the impact of the preoperative CRP/ALB ratio on the PFS and OS of dogs with oral melanoma. The CRP/ALB ratio and frequency of circulating Tregs are potential prognostic markers in dogs with oral melanoma.

Neutrophil-lymphocyte ratio: an independent predictor of the herpes zoster risk in rheumatoid arthritis patients treated with tofacitinib

“…By suppressing T-cell proliferation and cytotoxic activity through the binding of PD-L1 on the surface of neutrophils to PD-1 on the surface of T cells, neutrophil activation can result in immunosuppression 37 . Inflammation and immune suppression are linked to circulating myeloid-derived suppressor cells, which are substantially connected with NLR 38 39 . Thus, elevated NLR indicates inhibition of the proliferation of T and B lymphocytes and immune suppression, which may be related to HZ infection.…”

Data-driven analysis to identify prognostic immune-related biomarkers in BRAF mutated cutaneous melanoma microenvironment

“…There were significant differences in immune-infiltration between the two groups, which may help to identify groups that are more responsive to BRAF inhibitors. Monocyte-lymphocyte ratio (MLR) is considered to be an important indicator of tumor prognosis ( Garcia et al, 2022 ). It has been reported that cancer-associated Macrophage play a key role in tumor progression, angiogenesis, invasion and recruitment of immunosuppressive cells ( Samain and Sanz-Moreno, 2020 ).…”

Exosomes: A potential tool for immunotherapy of ovarian cancer

“…found that engineered SPION-NNVs can be widely and efficiently used in clinical transformation, which has great application significance in the field of drug targeted delivery and tumor therapy. As persistent inflammation is a major feature of the TME, targeted therapy of the inflammatory TME is a research hotspot ( 241 , 242 ). Some researchers have developed the NEs-Exos system for glioma using N-Ex as delivery vehicles for doxorubicin ( 107 ).…”